Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Tizzano, E. F.    Buchwald, M.    Related Articles in PubMed    PubMed Citation    PubMed

PERSPECTIVE

CFTR Expression and Organ Damage in Cystic Fibrosis

Eduardo F. Tizzano and Manuel Buchwald

15 August 1995 | Volume 123 Issue 4 | Pages 305-308

The cloning of the defective gene in cystic fibrosis (CFTR) is the most important step to date toward understanding the pathogenesis of the disease and developing novel therapeutic strategies.Although many studies have provided insights into the molecular defects and knowledge of the expression and role of the gene, the basic defect and its pathogenesis are still unclear. We hypothesize that organ damage in cystic fibrosis is the result of a combination of at least three main factors: the genotype (the type of mutation that alters the function of the cystic fibrosis transmembrane regulator [CFTR]), the rate of CFTR-mediated chloride secretion in the epithelium of each organ (inferred from the level of expression of the gene), and the anatomical and physiologic characteristics of the affected organs (the size and contents of the ducts). Confirmation of this hypothesis should allow a better understanding of the pathogenesis of the disease and help prevent organ damage.

Author and Article Information

From Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, and the Hospital for Sick Children, Toronto, Ontario, Canada.
Requests for Reprints: Manuel Buchwald, PhD, Department of Genetics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8 Canada.
Acknowledgments: The authors thank Peter Durie and Sylvia Gartner for their helpful comments on the manuscript.
Grant Support: In part by grants from Institut de Recerca Hospital de Sant Pau, the Canadian Cystic Fibrosis Foundation, and Inspiraplex.

This article has been cited by other articles:

				M. C. Rose and J. A. Voynow Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and Disease Physiol Rev, January 1, 2006; 86(1): 245 - 278. [Abstract] [Full Text] [PDF]

				K. T. Kahle, I. Gimenez, H. Hassan, F. H. Wilson, R. D. Wong, B. Forbush, P. S. Aronson, and R. P. Lifton WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia PNAS, February 17, 2004; 101(7): 2064 - 2069. [Abstract] [Full Text] [PDF]

				M. Park, S. B. H. Ko, J. Y. Choi, G. Muallem, P. J. Thomas, A. Pushkin, M.-S. Lee, J. Y. Kim, M. G. Lee, S. Muallem, et al. The Cystic Fibrosis Transmembrane Conductance Regulator Interacts with and Regulates the Activity of the HCO3- Salvage Transporter Human Na+-HCO3- Cotransport Isoform 3 J. Biol. Chem., December 20, 2002; 277(52): 50503 - 50509. [Abstract] [Full Text] [PDF]

				Y. Loubieres, D. Grenet, B. Simon-Bouy, J. Medioni, P. Landais, C. Ferec, and M. Stern Association Between Genetically Determined Pancreatic Status and Lung Disease in Adult Cystic Fibrosis Patients Chest, January 1, 2002; 121(1): 73 - 80. [Abstract] [Full Text] [PDF]

				F P Edenborough Respiratory diseases in pregnancy {bullet} 4: Women with cystic fibrosis and their potential for reproduction Thorax, August 1, 2001; 56(8): 649 - 655. [Full Text] [PDF]